media won�t investigate medically-caused death numbers
.
please keep our community civil. comments should remain on topic and be respectful.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.ai-based software may help predict risk of dementia
.